Abstract. Positron emission tomography/computed tomography (PET/CT) with 18 F-fluoro-2-deoxyglucose (FDG-PET/CT) has become established in cancer imaging, and derived maximum standardized uptake values (SUVmax) add functional information regarding cancer, including esophageal squamous cell carcinoma (ESCC). The aim of the present study was to determine the clinical significance and association of tumor progression using SUVmax derived from PET/CT images in patients with ESCC. In total, 101 patients with ESCC were assessed using FDG-PET/CT and the SUVmax was then compared with the clinical backgrounds and prognoses of the patients. Endoscopic ESCC biopsy specimens were obtained in order to analyze mRNA expression relative to tumor progression. The results showed that values for SUVmax were significantly higher in patients with tumor progression factors, particularly those with lymph node metastasis. Analysis of receiver operating characteristics curves revealed an optimum SUVmax cut-off value of 10.26 for node-positive disease. Patients with SUVmax ≥10.26 had gene alterations with epithelial-mesenchymal transition (EMT) and significantly worse overall survival (P=0.0012). A higher SUVmax in patients with ESCC was associated with lymph node metastasis and a poorer prognosis. Thus, the SUVmax may reflect the potential of EMT in patients with ESCC.
Introduction
Esophageal cancer is an extremely lethal gastrointestinal neoplasm that leads to >300,000 mortalities worldwide annually (1) . The reason for the poor prognosis is that >50% of patients already have unresectable or metastatic disease when they are diagnosed with esophageal cancer (2) . A precise evaluation of the prognosis or overall survival (OS) of patients with esophageal cancer is essential for selecting appropriate treatment. Positron emission tomography/computed tomography (PET/CT) has become established in cancer imaging, and is useful for stratification during the primary staging of esophageal cancer by anatomical factors, such as tumor depth, invasion, lymph node metastasis and distant metastasis (3) (4) (5) (6) (7) (8) (9) (10) . However, 18 F-fluoro-2-deoxyglucose (FDG)-PET may be used to evaluate functional factors associated with tumor activity, which depends on glucose metabolism.
It has been previously reported that the maximum standardized uptake value (SUVmax) in patients with certain types of cancer significantly correlates with survival, prognosis and recurrence (11, 12) . Although the clinical significance of SUVmax in esophageal cancer has been reported (13, 14) , the progression of esophageal cancer in specimens of esophageal squamous cell carcinoma (ESCC) using gene analysis has not yet been assessed. Therefore we investigated whether the Maximum standardized uptake value in 18 F-fluoro-2-deoxyglucose positron emission tomography is associated with advanced tumor factors in esophageal cancer SUVmax derived from FDG-PET/CT is associated with tumor progression and prognosis. We also compared gene alterations in ESCC biopsy specimens with SUVmax to determine factors that are associated with tumor progression and prognosis.
Materials and methods
Patients. Biopsy specimens of ESCC were obtained from 101 treatment-naïve patients who underwent endoscopy between March 2007 and January 2010 at the National Hospital Organization Shikoku Cancer Center. The patients had not undergone prior endoscopic mucosal resection, chemotherapy, radiotherapy or surgery and had no other active malignancies. Pretreatment tumor specimens were collected by endoscopic biopsy subsequent to obtaining written informed consent from each patient. These and all other specimens were histologically proven as ESCC. The patients were assessed using FDG-PET/CT, and then the SUVmax for each primary tumor was calculated. Tumors were clinically staged according to the criteria of the tumor-node-metastasis (TNM) classification of the International Union Against Cancer (15) . The study protocol conformed to the ethical guidelines of the Declaration of Helsinki, and the Institutional Review Board of the National Hospital Organization Shikoku Cancer Center approved this study (approval no. H18-34).
FDG-PET/CT imaging.
Patients were examined by PET/CT imaging using Aquiduo (Toshiba Medical Systems Corporation, Otawara, Japan), which provides separate CT and PET datasets that can be accurately combined on a computer workstation. Whole-body CT [Auto-mA (SDN), 120 kV, 2.0 mm x 16, 0.5 sec, 30 mm/rotation (HP15), 2-and 4-mm incremental reconstructions] covered the region from the head to the upper femoral regions. The PET component of the combined imaging system has an axial field of view of 16.2 cm (per bed position) with an in-plane spatial resolution of 4.6 mm. PET images in the same field of view as the CT were obtained over a period of 90 min following the administration of 3.0 MBq/kg body weight of FDG. The duration of PET image acquisition was adapted according to the weight of each patient. Images were scatter-corrected and reconstructed with and without PET attenuation correction, which was based on the CT data. Prior to injecting the radioactive tracer, blood was sampled to ensure that blood glucose levels were within the normal range. The single-pixel SUVmax normalized using lean body mass was quantified in the primary tumor when uptake was abnormal.
Polymerase chain reaction (PCR) array analysis.
Cancer-related genes from ESCC specimens were comprehensively analyzed using RT2 Statistical analysis. Data were statistically analyzed using JMP 9.0 software (SAS Institute, Cary, NC, USA). Associations between SUVmax and clinical variables as well as mRNA expression were evaluated using the Wilcoxon rank-sum test for significance. Independent variables contributing to SUVmax were evaluated by linear regression analysis and included in the multivariate analysis. To stratify patients with high and low SUVmax, the optimum cut-off value was defined as the point of the receiver operating characteristic curve with the maximum Youden index: sensitivity + specificity -100% (16). Survival curves were generated using the Kaplan-Meier method, and statistical differences between curves were calculated using the log-rank test. Statistical significance was defined as P<0.05 based on a two-tailed test.
Results
Patient characteristics. 
Expression of cancer-related genes and GLUT-1 in patients with ESCC.
Receiver operating characteristics curves for the N stage were analyzed to determine the optimum cut-off value in order to differentiate groups with a high and low SUVmax. Receiver operating characteristics curve for N stage and maximum standardized uptake value (SUVmax). Optimum cut-off value for SUVmax for differentiating a high and low SUVmax was determined by analyzing receiver operating characteristics curves for N stage. Optimum SUVmax cut-off value that differentiated a positive and negative tumor metastasis to lymph nodes was 10.26 with 94.0%, sensitivity and 76.5% specificity.
The optimum SUVmax cut-off for discriminating positive and negative tumor metastasis to lymph nodes was 10.26 ( Fig. 1) .
The sensitivity was 94.0% and the specificity was 76.5%.
Expression of cancer-related genes and GLUT-1 (a key FDG transporter in cancer cells) was compared between patients with high and low SUVmax. We comprehensively analyzed which cancer-related genes were associated with SUVmax using a PCR array for the cancer pathway (Table IV) and mRNA (0.5 µg) in biopsy specimens from the three patients each with the highest and lowest SUVmax. Genes related to the EMT signaling pathway (integrins and MMPs) were expressed at 2-fold higher levels in the three patients with the lowest SUVmax. Therefore genes involved in the EMT signaling pathway were analyzed using a PCR array Genes indicated in bold type were up-or downregulated by a difference of >2-fold between the two groups. Table IV . PCR array for cancer pathway-related genes. (Table V) . Table VI shows the 21 cancer-or EMT-related genes that required additional investigation. To confirm differences between a high and low SUVmax, mRNA isolated from the ESCC of all 101 patients was analyzed using qPCR and Table V . PCR array for epithelial-mesenchymal transition (EMT) related genes. gene-specific primers (Table VI) . E-cadherin mRNA expression was significantly lower in the group with a high compared with a low SUVmax (P= 0.0351). Differences in these genes were compatible with EMT induction and with an increased SUVmax in ESCC. However, GLUT-1 mRNA expression did not significantly differ between the groups with a high and low SUVmax.
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Levels of SUVmax are associated with OS.
We analyzed the prognosis of patients with SUVmax above and below the 10.26 cut-off value. The median follow-up duration of all the patients was 26.5 months (range, 0.67-55.8). The median OS of all patients was 49.8 months, and the 3-year survival rate was 55.3%. The survival rate was significantly poorer in the group with a higher SUVmax (Fig. 2) . The median OS of patients with a high SUVmax was 27.0 months (hazard ratio, 3.77; 95% CI, 1.71-9.94; P=0.0012), whereas that of patients with a low SUVmax did not reach the median.
Discussion
In the present study, we analyzed the association between clinical variables and SUVmax derived from FDG-PET/CT at the time of initial diagnosis. We also examined the mRNA levels of cancer-related genes from biopsy specimens of ESCC to compare tumor progression with SUVmax. The SUVmax Table VI . Gene expression in groups with low and high SUVmax. Survival curves for groups with high and low maximum standardized uptake values (SUVmax). Survival rates are significantly poorer in the group with a higher SUVmax compared with the group with a lower SUVmax. Overall survival (OS) did not reach median in patients with a low SUVmax, whereas median OS was 27.0 months in those with a high SUVmax (hazard ratio, 3.77; 95% confidence interval, 1.71-9.94; P= 0.0012).
was associated with tumor progression factors, particularly with lymph node metastasis. A higher SUVmax is associated with modulated genes involved in EMT formation, which would be linked to an advanced clinical N stage. The current TNM classification for esophageal cancer is based only on anatomical factors as compared to functional factors such as FDG uptake (15) . However, mounting evidence suggests that functional factors are involved in tumor progression and prognosis, although possibly not to a greater extent than anatomical factors in esophageal cancer (3) (4) (5) (6) (7) (8) (9) (10) . Non-invasive FDG-PET/CT may aid in the detection of not only anatomical, but also some genetic, oncological, molecular and biological factors. Two studies that have examined the SUVmax of FDG-PET have also provided staging, biological and prognostic information regarding esophageal cancer (13, 14) . By contrast, other authors have reported that SUVmax is not a useful independent predictor of survival for patients with esophageal cancer (18, 19) . Those studies found that SUVmax correlates with TNM classification. Therefore, we considered that SUVmax is a parameter of tumor progression in ESCC. To the best of our knowledge, this is the first demonstration of the N stage being the most significant variable that contributes to the SUVmax of primary tumors, although two previous studies have identified FDG-positive lymph nodes as the most significant risk factor for recurrence and a predictor of poor outcome (14, 20) . Additional analysis is required to confirm the clinical implications of SUVmax in ESCC with lymph node metastasis.
EMT is essential for morphogenesis during embryonic development and is triggered during carcinoma progression to assume an invasive and metastatic state (21, 22) . The EMT may be reactivated in a variety of diseases, including fibrosis and cancer progression (23) . Growth factors, cytokines, extracellular matrix components and transcription factors are involved in EMT induction in epithelial tumor cells (21, 22) . Results of recent studies (24) (25) (26) (27) (28) (29) suggest that EMT is associated with tumor invasion, metastasis and prognosis in ESCC. However, an association between SUVmax derived from FDG-PET/CT and EMT markers in ESCC remains to be determined. In the present study, we used qPCR to measure EMT marker expression in pretreated endoscopic esophageal tumor biopsy specimens. Among the EMT markers, we found that the expression of Snail, collagen-1α2, E-cadherin, FN-1, integrin-α5, MMP-1, MMP-2, N-cadherin, TIMP-1 and IL-8 significantly differed according to SUVmax in patients with ESCC. Additinoally, the transcription factor (Snail), extracellular matrix and cell adhesion factors (collagen-1α2, E-cadherin, FN-1, integrin-α5, MMP-1, MMP-2, N-cadherin and TIMP-1) and an angiogenesis factor (IL-8) contributed to the promotion of EMT (21) (22) (23) 30) .
E-cadherin is important in the regulation of intercellular adhesion in normal cell structures, as well as in cancer invasion and metastasis. Low E-cadherin expression was significantly associated with a high SUVmax in the present study. Previously, it was reported that reduced E-cadherin expression is associated with tumor invasion, metastasis and a poor prognosis for patients with ESCC (24, 25) . Our results are comparable with those findings. The direct transcriptional repression of E-cadherin results in the induction of EMT by Snail in epithelial cells. Therefore, Snail is important in the migration and invasive activity by repressing epithelial adhesion molecules, which contributes to deeper invasion, metastasis and a poor prognosis (24, 26) . Integrin promotes Snail expression through integrin-linked kinase activation (24) . MMP-2 expression, which is crucial in extracellular matrix remodelling, is significantly associated with tumor invasion and metastasis in ESCC (27) . TIMP-1 both inhibits MMPs and is crucial as a growth factor. The expression of TIMP-1 is associated with tumor progression and a poor prognosis (28) . N-cadherin is upregulated in invasive tumors, plays a key role in intercellular adhesion and is an important factor in ESCC tumor progression (29) .
The SUVmax in ESCC significantly correlates with the expression of GLUT-1, which is a GLUT (31) . However, we did not find a significant difference in GLUT-1 expression between a high and low SUVmax. We hypothesize that the tumor glucose metabolism is connected with EMT. Wnt/Snail signaling which inhibits mitochondrial respiration and induces glycolytic changes. The EMT may be a contributary factor to the Wnt/Snail regulation of mitochondrial function and glucose metabolism (32) . However, details of the molecular mechanisms of FDG uptake in tumors remain controversial. Assessments of FDG uptake during the EMT are therefore required.
Limitations of the present study should be considered. The original endoscopic biopsy specimens were small, and they might not have been representative of entire tumors due to intratumor heterogeneity. However, biopsy material frequently yields a representative genetic expression profile of total tumor tissue (33) , and biopsy specimens are the only tissue samples that can be conveniently obtained for this type of study. The second limitation is the definition of the optimum SUVmax cut-off because it depends on the method and/or FDG-PET/CT scanners. The significance of our cut-off SUVmax for prognosis may require re-evaluation at each institution. The third is that the patients had different stages of disease and underwent different therapies, which affect prognosis. However, the univariate analysis of OS revealed that the SUVmax derived from FDG-PET/CT was associated with the prognosis of patients with esophageal cancer.
In conclusion, findings of the present study have shown that a higher SUVmax derived from FDG-PET/CT is associated with lymph node metastasis and a poorer prognosis for patients with ESCC. Furthermore, tumor functional analysis at a higher SUVmax indicated the EMT tendency of ESCC. The usefulness of SUVmax should be validated in a clinical study.
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